Formation of platelet-leukocyte conjugates in whole blood.

The purpose of this investigation was to obtain information on platelet-leukocyte conjugate formation in whole blood and on factors that affect it. We also measured platelet and leukocyte activation by quantitating the expression of CD62P and CD11b. In both cases a flow cytometric approach was used. The results show that platelet-monocyte and platelet-polymorphonuclear leukocyte (PMNL) conjugate formation is enhanced by simply stirring blood, with optimum conjugate formation occurring after 10 min. In the case of monocytes,conjugate formation was enhanced by adenosine diphosphate (ADP). Both monocyte and PMNL conjugate formation was enhanced by phorbol myristate acetate (PMA), but L-formyl methionyl lysyl proline (FMLP) was either without effect (monocytes) or inhibitory (PMNL). EDTA also inhibited conjugate formation (implying involvement of divalent cations), as did dextran sulphate (implying involvement of P-selectin = CD62P). Interestingly GR144053F, which acts at GpIIb-IIIa on platelets to interfere with fibrinogen binding, and also glycyl prolyl arginyl proline (GPRP), a peptide that interferes with the interaction between CD11c on leukocytes and fibrinogen, did not inhibit platelet-monocyte conjugate formation, but did inhibit the platelet-PMNL interaction; this indicates that GpIIb-IIIa on platelets and CD11c on leukocytes and fibrinogen are involved in mediating the interaction between platelets and PMNL but not platelets and monocytes. Surprisingly arginyl-glycyl aspartyl serine (RGDS) inhibited the formation of both types of conjugate but this may be because it also inhibited both platelet and leukocyte activation as measured by CD62P and CD11b exposure and/or interferes with the binding of adhesion molecules other than fibrinogen. The results show that a flow cytometric procedure can be effective in obtaining rapid information on platelet-leukocyte conjugate formation in whole blood and on factors that are involved in its regulation. It is suggested that the technique may be applicable to the study of platelet-leukocyte conjugate formation in whole blood in disease, and also to study the effects of drugs interfering with conjugate formation.

[1]  A. Weyrich,et al.  Activated platelets signal chemokine synthesis by human monocytes. , 1996, The Journal of clinical investigation.

[2]  S. Heptinstall,et al.  Contact-induced modulation of neutrophil elastase secretion and phagocytic activity by platelets. , 1996, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[3]  S. Heptinstall,et al.  Studies on the effects of agonists and antagonists on platelet shape change and platelet aggregation in whole blood. , 1996, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[4]  M. Gawaz,et al.  Platelet activation and interaction with leucocytes in patients with sepsis or multiple organ failure , 1995, European journal of clinical investigation.

[5]  G. Zimmerman,et al.  Activation of polymorphonuclear leukocytes reduces their adhesion to P-selectin and causes redistribution of ligands for P-selectin on their surfaces. , 1995, The Journal of clinical investigation.

[6]  A. Weyrich,et al.  Monocyte tethering by P-selectin regulates monocyte chemotactic protein-1 and tumor necrosis factor-alpha secretion. Signal integration and NF-kappa B translocation. , 1995, The Journal of clinical investigation.

[7]  C. Smith,et al.  Leukocyte activation with platelet adhesion after coronary angioplasty: a mechanism for recurrent disease? , 1995, Journal of the American College of Cardiology.

[8]  B. Smith,et al.  Neutrophil but not Monocyte Activation Inhibits P-Selectin-Mediated Platelet Adhesion , 1994, Thrombosis and Haemostasis.

[9]  M. Horton,et al.  Fibrinogen mediates platelet-polymorphonuclear leukocyte cooperation during immune-complex glomerulonephritis in rats. , 1994, The Journal of clinical investigation.

[10]  M. Gawaz,et al.  Platelet-leukocyte aggregation during hemodialysis. , 1994, Kidney international.

[11]  L. Lasky.  A sweet success , 1994, Nature Structural Biology.

[12]  B. Kehrel,et al.  The Platelet Glycoprotein IIb/IIIa Complex Is lnvolved in the Adhesion of Activated Platelets to Leukocytes , 1993, Thrombosis and Haemostasis.

[13]  J. White,et al.  Cathepsin G-dependent platelet stimulation by activated polymorphonuclear leukocytes and its inhibition by antiproteinases: role of P-selectin-mediated cell-cell adhesion. , 1993, Blood.

[14]  A. Sonnenberg,et al.  P-selectin mediates Ca(2+)-dependent adhesion of activated platelets to many different types of leukocytes: detection by flow cytometry. , 1992, Blood.

[15]  B. Smith,et al.  Activated and unactivated platelet adhesion to monocytes and neutrophils. , 1991, Blood.

[16]  C. Abrams,et al.  Immunological Detection of Activated Platelets in Clinical Disorders , 1991, Thrombosis and Haemostasis.

[17]  J. Loike,et al.  CD11c/CD18 on neutrophils recognizes a domain at the N terminus of the A alpha chain of fibrinogen. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[18]  S. Heptinstall,et al.  Glucose increases spontaneous platelet aggregation in whole blood. , 1990, Thrombosis research.

[19]  R. Silverstein,et al.  Thrombospondin binds to monocytes-macrophages and mediates platelet-monocyte adhesion. , 1987, The Journal of clinical investigation.

[20]  E Ruoslahti,et al.  The effect of Arg-Gly-Asp-containing peptides on fibrinogen and von Willebrand factor binding to platelets. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[21]  Berger,et al.  Human neutrophils increase expression of C3bi as well as C3b receptors upon activation. , 1984, The Journal of clinical investigation.

[22]  T. Jungi,et al.  Interaction: Selective Binding of Thrombin-Stimulated Platelets to Human Monocytes, Polymorphonuclear Leukocytes, and Related Cell Lines , 2017 .

[23]  V. Ullrich,et al.  Platelet-Neutrophil Interactions , 1991 .